![Kenzo Nakajima](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenzo Nakajima
No más puestos en curso
Perfil
Kenzo Nakajima was the Chief Executive Officer of Stem Cell Sciences KK, Director-Legal & General Affairs of Smithkline Beecham Seiyaku K.K., Principal at Fujisawa Pharmaceutical Co., Ltd., Chief Operating Officer of Sosei Co. Ltd., and Legal Officer of NapaJen Pharma, Inc.
Antiguos cargos conocidos de Kenzo Nakajima.
Empresas | Cargo | Fin |
---|---|---|
Fujisawa Pharmaceutical Co., Ltd.
![]() Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Corporate Officer/Principal | 01/01/1990 |
Stem Cell Sciences KK
![]() Stem Cell Sciences KK BiotechnologyHealth Technology Stem Cell Sciences KK specializes in the research and development of embryonic stem cell regenerative therapies. It develops and commercializes technologies related to the process and purification of stem cells. The firm offers discovery platform technologies relating to the growth, differentiation, and purification of embryonic stem cells. Its technologies provide a range of purified cell types, such as neurons and cardiac cells, for gene and drug discovery. The company was founded on April 5, 2002 and is headquartered in Kobe, Japan. | Director Ejecutivo | - |
Sosei Co. Ltd.
![]() Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sosei Group Corp., Sosei Co. Ltd. is a world-leader in GPCR medicine design and development. The company is based in Tokyo, Japan. The Japanese company obtains and maintains intellectual property rights to protect its innovations and technologies. | Director de Operaciones | - |
Smithkline Beecham Seiyaku K.K. | Consejero General | - |
NapaJen Pharma, Inc.
![]() NapaJen Pharma, Inc. Pharmaceuticals: MajorHealth Technology NapaJen Pharma, Inc. develops drug delivery technology solutions through cellular transport pathways. Its products include lead platform and drug delivery. The firm specializes in the development of novel drug delivery systems by utilizing natural transport pathways whose cells are used to move molecular cargo into themselves and across internal compartments. The company was founded by Dr. Kazuo Sakurai and Hironori Ando in December 2004 and is headquartered in Burlingame, CA. | Consejero General | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 5 |
---|---|
NapaJen Pharma, Inc.
![]() NapaJen Pharma, Inc. Pharmaceuticals: MajorHealth Technology NapaJen Pharma, Inc. develops drug delivery technology solutions through cellular transport pathways. Its products include lead platform and drug delivery. The firm specializes in the development of novel drug delivery systems by utilizing natural transport pathways whose cells are used to move molecular cargo into themselves and across internal compartments. The company was founded by Dr. Kazuo Sakurai and Hironori Ando in December 2004 and is headquartered in Burlingame, CA. | Health Technology |
Fujisawa Pharmaceutical Co., Ltd.
![]() Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Health Technology |
Smithkline Beecham Seiyaku K.K. | |
Sosei Co. Ltd.
![]() Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sosei Group Corp., Sosei Co. Ltd. is a world-leader in GPCR medicine design and development. The company is based in Tokyo, Japan. The Japanese company obtains and maintains intellectual property rights to protect its innovations and technologies. | Commercial Services |
Stem Cell Sciences KK
![]() Stem Cell Sciences KK BiotechnologyHealth Technology Stem Cell Sciences KK specializes in the research and development of embryonic stem cell regenerative therapies. It develops and commercializes technologies related to the process and purification of stem cells. The firm offers discovery platform technologies relating to the growth, differentiation, and purification of embryonic stem cells. Its technologies provide a range of purified cell types, such as neurons and cardiac cells, for gene and drug discovery. The company was founded on April 5, 2002 and is headquartered in Kobe, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Kenzo Nakajima